Zepbound 7.5mg  for weightloss

On November 8, 2023, Eli Lilly and Company’s obesity treatment Zepbound™ was approved by the U.S. Food and Drug Administration (FDA). It is projected to work better compared to other weight loss drugs on the market Zepbound 7.5mg  .

Zepbound 7.5mg

Zepbound has a unique mechanism of action that sets it apart from other weight-loss medications. It activates two hormone receptors in the body called GIP and GLP-1 receptors. GLP-1 is a hormone that helps regulate appetite and food intake. Based on preliminary lab studies, GIP is another hormone that may further reduce food cravings and calorie consumption when combined with GLP-1. It is designed to supplement diet and exercise and helps with chronic weight management.

What is Zepbound?

Zepbound is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. Zepbound should be used with a reduced-calorie diet and increased physical activity.

• Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines.
• It is not known if Zepbound is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products.
• It is not known if Zepbound can be used in people who have had pancreatitis.
• It is not known if Zepbound is safe and effective for use in children under 18 years of age.

Safety Warnings 

Zepbound may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.

• Do not use Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
• Do not use Zepbound if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Do not use Zepbound if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Zepbound.